title: Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein.
abstract: Multiple tumorigenic pathways converge on the activating protein-1 (AP-1) family of dimeric transcription complexes by affecting transcription, mRNA decay, posttranslational modifications, as well as stability of its JUN and FOS components. Several mechanisms have been implicated in the phosphorylation- and ubiquitylation-dependent control of c-Jun protein stability. Although its dimer composition has a major role in the regulation of AP-1, little is known about the influence of heterodimerization partners on the half-life of c-Jun. The FOS family member Fra-1 is overexpressed in various tumors and cancer cell lines wherein it controls motility, invasiveness, cell survival and cell division. Oncogene-induced accumulation of Fra-1 results from both increased transcription and phosphorylation-dependent stabilization of the protein. In this report, we describe a novel role of Fra-1 as a posttranslational regulator of c-Jun. By using both constitutively and inducible transformed rat thyroid cell lines, we found that c-Jun is stabilized in response to RAS oncoprotein expression. This stabilization requires the activity of the extracellular signal-related kinase (ERK) pathway, along with c-Jun heterodimerization with Fra-1. In particular, heterodimerization with Fra-1 inhibits c-Jun breakdown by a mechanism dependent on the phosphorylation of the Fra-1 C-terminal domain that positively controls the stability of the protein in response to ERK signaling. Therefore, Fra-1 modulates AP-1 dimer composition by promoting the accumulation of c-Jun in response to oncogenic RAS signaling.
authors.affiliation: Institute of Genetics and Biophysics 'A. Buzzati Traverso,' CNR, Naples, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Talotta
authors.forename: T
authors.initials: T
authors.lastname: Mega
authors.forename: G
authors.initials: G
authors.lastname: Bossis
authors.forename: L
authors.initials: L
authors.lastname: Casalino
authors.forename: J
authors.initials: J
authors.lastname: Basbous
authors.forename: I
authors.initials: I
authors.lastname: Jariel-Encontre
authors.forename: M
authors.initials: M
authors.lastname: Piechaczyk
authors.forename: P
authors.initials: P
authors.lastname: Verde
mesh_terms: D000818:Animals; D002461:Cell Line, Transformed; D019281:Dimerization; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D020935:MAP Kinase Signaling System; D010766:Phosphorylation; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D016755:Proto-Oncogene Proteins c-jun / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D013961:Thyroid Gland / Q000201:enzymology / Q000378:metabolism; D018808:Transcription Factor AP-1 / Q000378:metabolism; D015854:Up-Regulation; D018631:ras Proteins / Q000096:biosynthesis / Q000235:genetics; D000099169:Fos-Related Antigen 1
chemical_list: D048049:Extracellular Signal-Regulated MAP Kinases; D016760:Proto-Oncogene Proteins c-fos; D016755:Proto-Oncogene Proteins c-jun; D018808:Transcription Factor AP-1; D018631:ras Proteins; D000099169:Fos-Related Antigen 1